$Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.$

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Seeman, A, McClung, M, Zippel, H, Bensen, W, Cooper, C, Benhamou, C, DiGennaro, J, Zorich, N, Reginster, J
التنسيق:	Journal article
منشور في:	2000

مواد مشابهة

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
حسب: Cooper, C, وآخرون
منشور في: (2001)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
حسب: Tahir Masud, وآخرون
منشور في: (2009-11-01)

Once-monthly risedronate for postmenopausal osteoporosis
حسب: Kristina Casadei, وآخرون
منشور في: (2009-02-01)

Romosozumab for the treatment of osteoporosis
حسب: Michael R. McClung
منشور في: (2018-03-01)

Emerging Therapies for Osteoporosis
حسب: Michael R. McClung
منشور في: (2015-12-01)

Denosumab for the treatment of osteoporosis
حسب: Michael R. McClung
منشور في: (2017-03-01)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
حسب: Raja Bobba, وآخرون
منشور في: (2007-10-01)

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.
حسب: Sorensen, O, وآخرون
منشور في: (2003)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
حسب: María J Moro-Álvarez, وآخرون
منشور في: (2008-06-01)

The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
حسب: Mizue Tanaka, وآخرون
منشور في: (2014-01-01)

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation
حسب: Boyanov M, وآخرون
منشور في: (2012-04-01)

Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis
حسب: Ban Hadi Hameed
منشور في: (2018-10-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
حسب: Paula Rackoff
منشور في: (2009-05-01)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
حسب: Stefano Palomba, وآخرون
منشور في: (2010-06-01)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
حسب: Delmas, P, وآخرون
منشور في: (2005)

The International Osteoporosis Foundation: history, objectives and achievements.
حسب: Cooper, C, وآخرون
منشور في: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
حسب: Cooper, C, وآخرون
منشور في: (2009)

THE EFFECTIVENESS OF ZINC AND RISEDRONATE ON BONE TURNOVER IN RAT MODEL OF OSTEOPOROSIS ASSESSED WITH THE EXPRESSION OF β-CROSSLAPS
حسب: Adam Fajar, وآخرون
منشور في: (2019-12-01)

Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement
حسب: Zoya Saifi, وآخرون
منشور في: (2023-09-01)

Identification and treatment of osteoporosis among elderly patients with hip fractures
حسب: Erika Satomi, وآخرون
منشور في: (2009-01-01)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
حسب: Watts, N, وآخرون
منشور في: (2004)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
حسب: M Stevenson, وآخرون
منشور في: (2005-06-01)

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
حسب: Seeman, E, وآخرون
منشور في: (2010)

A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis
حسب: Satoshi Soen, وآخرون
منشور في: (2020-12-01)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
حسب: Ma. Florencia Peralta, وآخرون
منشور في: (2021-05-01)

Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
حسب: Bala, Y, وآخرون
منشور في: (2014)

Telecarers improve osteoporosis treatment and compliance rates in secondary osteoporosis prevention for elderly hip fracture patients
حسب: Linsey Utami Gani, وآخرون
منشور في: (2023-04-01)

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
حسب: Miller, P, وآخرون
منشور في: (2005)

Calcium and Strontium Coordination Polymers as Controlled Delivery Systems of the Anti-Osteoporosis Drug Risedronate and the Augmenting Effect of Solubilizers
حسب: Maria Vassaki, وآخرون
منشور في: (2021-12-01)

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
حسب: Calabria S, وآخرون
منشور في: (2016-04-01)

Osteoclast and Sclerostin Expression in Osteocytes in the Femoral Head with Risedronate Therapy in Patients with Hip Fractures: A Retrospective Comparative Study
حسب: Hwan-Hee Lee, وآخرون
منشور في: (2022-10-01)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
حسب: J Y Reginster, وآخرون
منشور في: (2011-04-01)

Reduced Awareness for Osteoporosis in Hip Fracture Patients Compared to Elderly Patients Undergoing Elective Hip Replacement
حسب: Moritz Kraus, وآخرون
منشور في: (2022-10-01)

Abdominal fat and hip fracture risk in the elderly: The Dubbo Osteoporosis Epidemiology Study
حسب: Center Jacqueline R, وآخرون
منشور في: (2005-02-01)

Expansion of the circadian transcriptome in Brassica rapa and genome-wide diversification of paralog expression patterns
حسب: Kathleen Greenham, وآخرون
منشور في: (2020-09-01)

Formulation and assessment of penetration potential of Risedronate chitosan nanoparticles loaded transdermal gel in the management of osteoporosis: In vitro and ex vivo screening
حسب: Sandhya Pathak, وآخرون
منشور في: (2024-06-01)

Assessment and management of osteoporosis in elderly people
حسب: Dennison, E, وآخرون
منشور في: (2000)

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
حسب: Ammarin Suwan, وآخرون
منشور في: (2024-10-01)

Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
حسب: Ercan Madenci, وآخرون
منشور في: (2003-06-01)

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
حسب: Vasikaran, S, وآخرون
منشور في: (2011)